These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29860528)

  • 1. Deriving a No Expected Sensitization Induction Level for Fragrance Ingredients Without Animal Testing: An Integrated Approach Applied to Specific Case Studies.
    Natsch A; Emter R; Haupt T; Ellis G
    Toxicol Sci; 2018 Sep; 165(1):170-185. PubMed ID: 29860528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between experimental human and murine skin sensitization induction thresholds.
    Api AM; Basketter D; Lalko J
    Cutan Ocul Toxicol; 2015; 34(4):298-302. PubMed ID: 25430073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjustment of a no expected sensitization induction level derived from Bayesian network integrated testing strategy for skin sensitization risk assessment.
    Otsubo Y; Nishijo T; Mizumachi H; Saito K; Miyazawa M; Sakaguchi H
    J Toxicol Sci; 2020; 45(1):57-67. PubMed ID: 31932558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation of the no expected sensitization induction level for dermal quantitative risk assessment of fragrance ingredients using a weight of evidence approach.
    Lee I; Na M; Lavelle M; Api AM
    Food Chem Toxicol; 2022 Jan; 159():112705. PubMed ID: 34838676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian integrated testing strategy (ITS) for skin sensitization potency assessment: a decision support system for quantitative weight of evidence and adaptive testing strategy.
    Jaworska JS; Natsch A; Ryan C; Strickland J; Ashikaga T; Miyazawa M
    Arch Toxicol; 2015 Dec; 89(12):2355-83. PubMed ID: 26612363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of in vitro testing to identify an unexpected skin sensitizing impurity in a commercial product: a case study.
    Natsch A; Gfeller H; Emter R; Ellis G
    Toxicol In Vitro; 2010 Mar; 24(2):411-6. PubMed ID: 19883749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin sensitization testing in potency and risk assessment.
    Kimber I; Basketter DA; Berthold K; Butler M; Garrigue JL; Lea L; Newsome C; Roggeband R; Steiling W; Stropp G; Waterman S; Wiemann C
    Toxicol Sci; 2001 Feb; 59(2):198-208. PubMed ID: 11158712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can currently available non-animal methods detect pre and pro-haptens relevant for skin sensitization?
    Patlewicz G; Casati S; Basketter DA; Asturiol D; Roberts DW; Lepoittevin JP; Worth AP; Aschberger K
    Regul Toxicol Pharmacol; 2016 Dec; 82():147-155. PubMed ID: 27569201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of skin sensitization potency using machine learning approaches.
    Zang Q; Paris M; Lehmann DM; Bell S; Kleinstreuer N; Allen D; Matheson J; Jacobs A; Casey W; Strickland J
    J Appl Toxicol; 2017 Jul; 37(7):792-805. PubMed ID: 28074598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated skin sensitization assessment based on OECD methods (I): Deriving a point of departure for risk assessment.
    Natsch A; Gerberick GF
    ALTEX; 2022; 39(4):636-646. PubMed ID: 35404469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-animal assessment of skin sensitization hazard: Is an integrated testing strategy needed, and if so what should be integrated?
    Roberts DW; Patlewicz G
    J Appl Toxicol; 2018 Jan; 38(1):41-50. PubMed ID: 28543848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin sensitization potency of isoeugenol and its dimers evaluated by a non-radioisotopic modification of the local lymph node assay and guinea pig maximization test.
    Takeyoshi M; Iida K; Suzuki K; Yamazaki S
    J Appl Toxicol; 2008 May; 28(4):530-4. PubMed ID: 17929237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Assessment of residual monomer migrating from acrylic polymers and causing Allergic Contact Dermatitis during normal handling and use.
    Pemberton MA; Lohmann BS
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):467-75. PubMed ID: 24859074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated decision strategies for skin sensitization hazard.
    Strickland J; Zang Q; Kleinstreuer N; Paris M; Lehmann DM; Choksi N; Matheson J; Jacobs A; Lowit A; Allen D; Casey W
    J Appl Toxicol; 2016 Sep; 36(9):1150-62. PubMed ID: 26851134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients.
    Api AM; Basketter DA; Cadby PA; Cano MF; Ellis G; Gerberick GF; Griem P; McNamee PM; Ryan CA; Safford R
    Regul Toxicol Pharmacol; 2008 Oct; 52(1):3-23. PubMed ID: 18406028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstructed human epidermis-based testing strategy of skin sensitization potential and potency classification using epidermal sensitization assay and in silico data.
    Mizumachi H; Suzuki S; Sakuma M; Natsui M; Imai N; Miyazawa M
    J Appl Toxicol; 2024 Mar; 44(3):415-427. PubMed ID: 37846211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
    Gerberick GF; Ryan CA; Dearman RJ; Kimber I
    Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Filling the concept with data: integrating data from different in vitro and in silico assays on skin sensitizers to explore the battery approach for animal-free skin sensitization testing.
    Natsch A; Emter R; Ellis G
    Toxicol Sci; 2009 Jan; 107(1):106-21. PubMed ID: 18832184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact allergenic potency: correlation of human and local lymph node assay data.
    Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
    Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of human contact allergens in the murine local lymph node assay.
    Ryan CA; Gerberick GF; Cruse LW; Basketter DA; Lea L; Blaikie L; Dearman RJ; Warbrick EV; Kimber I
    Contact Dermatitis; 2000 Aug; 43(2):95-102. PubMed ID: 10945748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.